Alliance
C4U and Cyto-Facto enter into Collaborative Research Agreement
C4U and Cyto-Facto have entered into a collaborative research agreement to explore the possibility of developing novel gene-edited cell therapy products utilizing CRISPR-Cas3 genome editing technology.